Novo Nordisk chair, independent directors to exit in row
The chairman of Novo Nordisk and six other independent board members quit today after a dispute with the company's controlling shareholder, as the drugmaker looks to revive sales of its blockbuster weight-loss drug Wegovy.
Business
• 21 Oct
